Affiliation:
1. Division of Geographic Medicine and Infectious Diseases, New England Medical Center, Boston, Massachusetts 02111
Abstract
ABSTRACT
In the 1980s, Shiga toxin (Stx)-producing
Escherichia coli
O157:H7 (STEC) was identified as a cause of hemorrhagic colitis in the United States and was found to be associated with hemolytic uremic syndrome (HUS), a microangiopathic hemolytic anemia characterized by thrombocytopenia and renal failure. The precise way that Stxs cause hemorrhagic colitis and HUS is unclear. Stxs have been thought to cause disease by killing or irreversibly harming sensitive cells through a nonspecific blockade of mRNA translation, eventually resulting in cytotoxicity by preventing synthesis of critical molecules needed to maintain cell integrity. Because STEC is noninvasive, we have been exploring the host-toxin response at the level of the gastrointestinal mucosa, where STEC infection begins. We have found that Stx is capable of interleukin-8 (IL-8) superinduction in a human colonic epithelial cell line. Despite a general blockade of mRNA translation, Stx treatment results in increased IL-8 mRNA as well as increased synthesis and secretion of IL-8 protein. Our data suggest that an active Stx A subunit is required for this activity. Ricin, which has the same enzymatic activity and trafficking pathway as Stx, has similar effects. Exploration of the effects of other protein synthesis inhibitors (cycloheximide, anisomycin) suggests a mechanism of gene regulation that is distinct from a general translational blockade. Use of the specific p38/RK inhibitor SB202190 showed that blocking of this pathway results in decreased Stx-mediated IL-8 secretion. Furthermore, Stxs induced mRNA of the primary response gene c-
jun
, which was subsequently partially blocked by SB202190. These data suggest a novel model of how Stxs contribute to disease, namely that Stxs may alter regulation of host cell processes in sensitive cells via activation of at least one member of the mitogen-activated protein kinase family in the p38/RK cascade and induction of c-
jun
mRNA. Stx-induced increases in chemokine synthesis from intestinal epithelial cells could be important in augmenting the host mucosal inflammatory response to STEC infection.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Immunology,Microbiology,Parasitology
Reference38 articles.
1. Acheson
D. W. K.
De Breucker
S. D.
Donahue-Rolfe
A.
Kozak
K.
Yi
A.
Keusch
G. T.
Development of a clinically useful diagnostic enzyme immunoassay for enterohemorrhagic Escherichia coli infection
Recent advances in verocytotoxin-producing E. coli infections.
Karmali
M. A.
Goglio
A. G.
1994
109
112
Elsevier Science
Amsterdam The Netherlands
2. Translocation of Shiga toxin across polarized intestinal cells in tissue culture
3. Acheson
D. W. K.
Effect of Shiga toxins on cytokine production from intestinal epithelial cells
Cytokines cholera and the gut.
Keusch
G. T.
Kawakami
M.
1996
67
73
IOS Press
Amsterdam The Netherlands
4. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1;Angel P.;Nature,1988
5. Blake
D. C. I.
Russell
R. G.
Santini
E.
Bowen
T.
Boedeker
E. C.
Pro-inflammatory mucosal cytokine responses to Shiga-like toxin-1 (SLT-1)
Cytokines cholera and the gut.
Keusch
G. T.
Kawakami
M.
1996
75
82
IOS Press
Amsterdam The Netherlands
Cited by
160 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献